Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275208 · ClinicalTrials.gov registry record
A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure
A clinical trial of Obesity, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 120
- Enrollment target
- 7
- Study locations
NCT02275208 is a study of Obesity that has completed, run by Medtronic - MITG. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT02275208, a study of Obesity, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.
Conditions Studied
Interventions
- PROCEDURE SIPS the stomach, intestinal, pylorus, sparing procedure
Study Locations (7)
New York
- - Mount Kisco
- - New York
North Carolina
- - Cary
- - Durham
Colorado
- - Parker
Florida
- Florida Hospital Celebration Health - Celebration
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-12-11 |
| Est. Completion | 2017-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02275208
The ClinicalTrials.gov registry entry for NCT02275208 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which SIPS the stomach, intestinal, pylorus, sparing procedure is the first listed.
NCT02275208 reports 7 study locations spanning 5 distinct geographic areas - top geographies include New York, North Carolina, Colorado.
Frequently Asked Questions
What is clinical trial NCT02275208 about?
NCT02275208 is a clinical study titled "A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure". This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.
What is the current status of trial NCT02275208?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-12-11. Estimated completion is 2017-01-18.
What conditions does trial NCT02275208 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02275208?
The interventions under investigation include: SIPS the stomach, intestinal, pylorus, sparing procedure (PROCEDURE).
Who is sponsoring clinical trial NCT02275208?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02275208 being conducted?
This trial has 7 study locations across Colorado, Florida, New York, North Carolina, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.